The major endpoints for clinical islet transplantation for type 1 diabetes are insulin independence and reduction of hypoglycemic episodes. Both endpoints are influenced by patients' and physicians' preferences regarding the use of exogenous insulin. Therefore, development of an objective endpoint for assessing clinical islet transplantation is desirable. HOMA-beta score is useful in assessing functional β-cell mass. However, this score uses blood insulin levels that are influenced by exogenous insulin injection and therefore is not suitable for patients who receive exogenous insulin. For assessing functional β-cell mass for type 1 diabetic patients after islet transplantation, we created the Secretory Unit of Islet Transplant Objects (SUITO) index using fasting C-peptide and fasting glucose. The formula of the SUITO index is fasting C-peptide (ng/ ml)/[fasting blood glucose − 63 (mg/dl)] × 1500. We demonstrated that, within 1 month of islet transplantation, an average SUITO index of >26 was an excellent predictor of achieving insulin independence. In addition, daily SUITO index scores correlated with a reduction of insulin dose and adversely correlated with blood glucose levels during an intravenous glucose tolerance test. Other important endpoints, reduction of hypoglycemic episodes and quality of life, also correlated with the SUITO index. Thus, the SUITO index is excellent for assessing important endpoints (insulin independence, reduction of hypoglycemia, improved quality of life) after allogeneic islet transplantation.
INTRODUCTION
clinical outcomes of islet transplantation is necessary. It is obvious that islet graft function directly correlates with clinical outcomes of islet transplantation. Islet transplantation is a promising treatment for type 1 diabetes (11, 26, 27) . Current major endpoints of islet Matthews et al. established homeostasis model assessment (HOMA) for both insulin resistance (HOMA-R) and transplantation are insulin independence and elimination of severe hypoglycemic episodes (11, 26, 27) . Insulin deficient β-cell function (HOMA-beta) (21) . HOMAbeta is useful in assessing functional islet mass. How-independence is influenced by patient and physician preferences. Some patients and physicians prefer to use ever, HOMA-beta includes the blood concentration of insulin and therefore cannot evaluate islet function for insulin more frequently to reduce hemoglobin A1c, and others prefer to minimize insulin use to avoid hypogly-patients who receive exogenous insulin. The recipients of islet transplantation are type 1 diabetes injected with cemia. Severe hypoglycemic episodes are defined as those involving a third party's help and the patient's exogenous insulin; hence, HOMA-beta is not applicable. To solve this issue, we introduced the Secretory Unit of hypoglycemic unawareness. The frequency of third-party help depends on the patient's social circumstances, and Islet Transplant Objects (SUITO) index, which can be calculated using blood glucose and C-peptide levels (20) . Of hypoglycemic unawareness depends on how frequently patients measure blood glucose levels. Therefore, both note, SUITO consists of SUI and TO, which means pancreas and island or islet in Japanese; therefore, SUITO insulin independence and elimination of severe hypoglycemia are subjective. An objective method to evaluate index means pancreatic islet index. In this review article, we describe the development and value of the SUITO secreted insulin is also high. Based on HOMA-beta (21) and data from normal healthy persons (35), we created the index for assessing clinical islet transplantation.
SUITO index to reflect functional mass (20 
Transplant Recipients
The SUITO index is 100 for normal healthy persons and 0 for type 1 diabetic patients with no ability to Steady-state basal plasma glucose and insulin consecrete insulin (Fig. 1 ). After islet transplantation, centrations are determined by their interaction in a feedpatients who achieve insulin independence secrete more back loop. A computer model has been used to predict C-peptide than patients who do not achieve insulin indethe homeostatic concentrations that arise from varying pendence at the same glucose levels, resulting in a high degrees of β-cell deficiency and insulin resistance. Com-SUITO index (Fig. 1 ). parison of a patient's fasting values with the model's predictions allows a quantitative assessment of the con-SUITO INDEX TO EVALUATE CLINICAL tributions of insulin resistance and deficient β-cell func-ISLET TRANSPLANTATION tion to fasting hyperglycemia (homeostasis model Prediction of Insulin Independence by Average SUITO assessment, HOMA) (21) . Insulin resistance (HOMA-R)
Index Within 1 Month of Islet Transplantation is calculated as follows: fasting blood insulin level (µU/ One of the endpoints of islet transplantation for the ml) × fasting blood glucose level (mg/dl)/405. A HOMAtreatment of type 1 diabetic patients is insulin indepen-R score of <1.6 is normal, and a score of >2.5 is considered dence (11, 26, 27) . We hypothesized that functional islet insulin resistance. β-Cell function (HOMA-beta) is calcumass during the first month after islet transplantation as lated as follows: fasting blood insulin level (µU/ml)/[fastassessed by the SUITO index could predict future insuing blood glucose level (mg/dl) − 63] × 360. A HOMA-beta lin independence. C-peptide is released from broken score <40 is considered decreased β-cell function.
islets up to 1 day after islet infusion (4), so C-peptide Candidates for islet transplant have unique characterlevels do not reflect functional islets in that period. istics. First, they lack insulin secretory ability. There-Therefore, we do not use C-peptide levels for the fore, both their HOMA-R and HOMA-beta scores are SUITO index at day 1 and 2 after islet transplantation. zero. While insulin secretory ability is zero, insulin
We calculated the average SUITO index of eight resistance is not necessarily zero. In fact, patients who patients after islet transplantation using pancreata from are insulin resistant cannot be candidates for islet transnon-heart-beating donors between postoperative days 3 plantation. Since the patients have no insulin secretory and 30 (20). When the average SUITO index was >26.0, ability, insulin resistance is diagnosed by a high body the patients were insulin independent. This suggested mass index (>30 kg/m 2 ) and daily insulin dose (>1.0 IU/ that >26% of functional β-cell mass is required for insukg body weight) (26).
lin independence. We also calculated the SUITO index After islet transplantation, the transplanted islets between postoperative days 3 and 30 for our first sucbegin secreting insulin. However, exogenous insulin cessful living-donor islet transplant patient (20). The injection is continued to enhance engraftment of transaverage SUITO index of this patient was 40.7, and the planted islets for several months. Even after achieving patient was insulin independent. insulin independence, the patients are encouraged to use Recently, we calculated the average SUITO index insulin injections when their blood glucose is high to between postoperative days 3 and 30 for patients who protect transplanted islets. Therefore, even after islet received islet transplants from pancreata from braintransplantation, the HOMA-beta score cannot reflect dead donors (19) . In this study, we used both the insulin secretory ability from islets. Thus, we thought a Edmonton-type protocol and our own protocol (Baylor new index using blood C-peptide levels would be useful protocol). Under the Edmonton-type protocol, three type in assessing the function of transplanted islets.
1 diabetic patients received islet transplantation twice.
Formula for SUITO Index
After the first islet transplantation, the average SUITO indices during the first month were 10-25 in all three After allogeneic islet transplantation, we and others noticed that the blood levels of C-peptide correlated with cases. None of the three patients achieved insulin independence. After the second islet transplantation, the those of glucose (5, 20, 22, 35) (Fig. 1 ). In addition, the ratio between C-peptide and glucose seemed to be associ-average SUITO indices during the first month posttransplantation were >26.0 in all three patients, and all three ated with islet graft function (Fig. 1 ). This suggested that transplanted functional islets secrete insulin based on achieved insulin independence. Under the Baylor protocol, three patients received single-donor islet transplan-blood glucose levels, and when the number of transplanted functional islets is high, the total amount of tation. All patients became insulin independent, and the average SUITO indices during the first month posttrans-has been insulin independent for more than 3 years. Thus, maintaining a high SUITO index with a transplan-plantation were >26.0.
Thus, based on the analysis of the SUITO index after tation of high islet yield might be one strategy to achieve long-term insulin independence. allogeneic islet transplantation using pancreata from non-heart-beating donors (17), a living donor (16, 18) , Correlation Between SUITO Index and Intravenous and brain-dead donors (12, 13, 19) , a SUITO index >26
Glucose Tolerance Test is associated with insulin independence.
The intravenous glucose tolerance test (IVGTT) is a Correlation Between SUITO Index and Daily standard evaluation method after islet transplantation Insulin Dose (25). However, this method requires bolus glucose injections and frequent blood glucose measurements. We We examined the correlation between daily SUITO index and reduction of insulin dose after islet transplan-examined whether the SUITO index, which is much simpler than IVGTT, correlated with the results of tation (12, 14) . Since the current standard protocols use intensive insulin therapy during the first month after IVGTT (30). Fifteen blood samples from each of six islet transplant recipients were examined before and islet transplantation, there was no correlation between the daily SUITO index and insulin reduction rate during after 3, 5, 10, 20, and 30 min of injection of 0.5 g/kg 50% dextrose. Glucose-level areas under the receiver-the first month after islet transplantation. However, after 2 months, the daily SUITO index strongly correlated operating characteristic curve (AUC) during IVGTT were assessed based on the SUITO index. The AUC was with the daily insulin dose (14). When the cutoff value of the daily SUITO index was set at 26 for insulin inde-significantly lower in cases with a SUITO index >10 than in cases with a SUITO index <10. In addition, pendence, the positive predictive value for a reduced insulin dose was 84.1%, and the negative predictive when the SUITO index was <10, glucose levels at baseline, 10, 20, and 30 min were significantly higher than value was 89.4%. Therefore, the daily SUITO index is also useful for assessing functional islet mass.
when the SUITO index was >10. Hence, a SUITO index <10 is associated with impaired islet function assessed We have a unique case in which a very high total dose of islets (>20,000 IEq/kg body weight) was trans-by IVGTT. Rickels et al. demonstrated that acute insulin planted after two islet transplantations (15). In this case, the average SUITO index within 1 month after the sec-response to glucose and arginine could predict β-cell secretory capacity in human islet transplantation (23) . ond islet transplantation was 48.5, and the daily SUITO index on postoperative day 1006 was 44.6. This patient In addition, glucose disappearance rate (K-value) during IVGTT (9) was also used to assess β-cell function after capacity using the difference between the basal Cpeptide levels before IVGTT and stimulated C-peptide islet transplantation (1,3,34). In our IVGTT, we only measured blood glucose for assessing acute response, levels at the end of IVGTT. The β-cell secretory capacity also significantly correlated with the SUITO index and then we examined the correlation between the Kvalue and the SUITO index. The K-value significantly (Spearman r = 0.581, p = 0.01) (Fig. 2B) . These findings suggest that the SUITO index can be a surrogate correlated with the SUITO index (Spearman r = 0.571, p = 0.01) ( Fig. 2A) . We also assessed β-cell secretory marker for IVGTT to assess the β-cell secretory capacity. Correlation Between SUITO Index status. Since the main purpose of islet transplantation is improving QOL, it is important to maintain a SUITO and Hypoglycemic Episodes index of at least 10. To assess the relationship between the frequency of hypoglycemic episodes and the SUITO index, data were OTHER APPLICATIONS OF THE SUITO INDEX examined from 310 clinical evaluations of 11 islet recipients (32) . Hypoglycemia was defined as a self-monitor-SUITO Index for Autologous Islet Transplantation ing blood glucose (SMBG) level <3.8 mmol/L. Severe Autologous islet transplantation after total pancreatehypoglycemia was defined as an SMBG level <2.2 ctomy is a useful treatment for chronic pancreatitis with mmol/L or the presence of hypoglycemic unawareness.
severe abdominal pain (10, 24, 28, 31, 33) . Islets are iso-Cases were categorized into three groups based on their lated from the removed pancreas, and isolated islets are SUITO index: low (<10), middle (10-25), and high immediately infused into the same patient (10) . To (≥ 26). The frequency of hypoglycemia in the highassess the correlation between the SUITO index and SUITO group was significantly lower than in the other metabolic outcomes of autologous islet transplantation, groups, including pretransplantation. The frequency of we analyzed 27 of our patients who received autologous total severe hypoglycemia was significantly lower in the islet transplantation. Cases were divided into an insulinlow-SUITO group compared to the pretransplant status independent group (N = 12) and an insulin-dependent and further decreased in the middle-and high-SUITO group (N = 15). The average SUITO index within the groups. Therefore, even the low-SUITO group benefited first month after transplantation, except for day 1 and 2, in the reduction of severe hypoglycemia.
was calculated in each case and was significantly higher in the insulin-independent group (24.6 ± 3.4 vs. 14.9 ± Correlation Between SUITO Index and Quality of Life 2.0; p < 0.02). Thus, the average SUITO index within Quality of life (QOL) is another important endpoint 1 month seems to be an excellent predictor of insulin for type 1 diabetic patients after islet transplantation independence after total pancreatectomy followed by (6, 7) . To elucidate the correlation between the SUITO autologous islet transplantation. index and QOL, we used the 36-item Short-Form Health Survey (SF-36), Diabetes Form 2.1, and the Insulin SUITO Index for Other Species Treatment Satisfaction Questionnaire (ITSQ) before transplant and 3, 6, 12, 18, and 24 months posttransplant Recently, Igarashi et al. performed islet xenotransplantation, transplanting pig islets into streptozotocin-(29). When the SUITO index was >10, an item of physical health in the SF-36 related to glycemic control and induced diabetic nonhuman primates (8) . They analyzed functional β-cell mass based on the SUITO index. The the total score in the ITSQ were significantly improved compared with the pretransplant status. In addition, SUITO index did not correlate with the β-cell mass. The normal blood glucose of nonhuman primates is very low when patients' SUITO index was >10, items related to physical health, energy, and emotions in the SF-36, compared with that in humans (2); therefore, fasting blood glucose minus 63 is not a suitable formula for items related to symptoms and social interactions in Diabetes Form 2.1, and items related to inconvenience of nonhuman primates. The authors created a new score using fasting blood glucose, daily glycosuria, postpran-regimen, glycemic control, and total score in the ITSQ were significantly higher compared with those who had dial glycosuria, polydipsia, and polyuria with excellent results. However, this score requires both blood and a SUITO index <10. Thus, a SUITO index >10 was associated with improvement of QOL after islet trans-urine samples and frequent measurement. A modified SUITO index for nonhuman primates should provide a plantation. Of note, when the SUITO index was <10, almost all items were worse than in the pretransplant simple and reliable assessment method. 
